ZynexZYXI
Market Cap: $249M
About: Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
Employees: 1,101
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
0.42% more ownership
Funds ownership: 30.21% [Q1] → 30.63% (+0.42%) [Q2]
7% less funds holding
Funds holding: 117 [Q1] → 109 (-8) [Q2]
25% less capital invested
Capital invested by funds: $120M [Q1] → $90.7M (-$29.5M) [Q2]
33% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 43
38% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 21
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
4 analyst ratings
HC Wainwright & Co. Yi Chen 32% 1-year accuracy 44 / 139 met price target | 104%upside $16 | Buy Reiterated | 4 Sept 2024 |
RBC Capital Shagun Singh 69% 1-year accuracy 43 / 62 met price target | 53%upside $12 | Outperform Maintained | 26 Jul 2024 |
HC Wainwright & Co. Yi Chen 32% 1-year accuracy 44 / 139 met price target | 104%upside $16 | Buy Maintained | 26 Jul 2024 |
RBC Capital Shagun Singh 69% 1-year accuracy 43 / 62 met price target | 91%upside $15 | Outperform Reiterated | 14 Jun 2024 |
Financial journalist opinion
Based on 6 articles about ZYXI published over the past 30 days